AI assistant
vTv Therapeutics Inc. — Director's Dealing 2021
Dec 21, 2021
34596_dirs_2021-12-21_b87d9efd-5c40-4f80-989b-6f0c56c5850b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: vTv Therapeutics Inc. (VTVT)
CIK: 0001641489
Period of Report: 2021-12-20
Reporting Person: PERELMAN RONALD O (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-20 | Class A Common Stock | S | 87000 | $1.15 | Disposed | 36519212 | Indirect |
Footnotes
F1: The ROP Revocable Trust dated 1/9/2018 (the "ROP Revocable Trust"), of which Mr. Ronald O. Perelman is the sole trustee and sole beneficiary, is the sole stockholder of MacAndrews & Forbes Incorporated ("M&F Inc."), which is the parent of MFV Holdings One LLC ("MFV") and MacAndrews & Forbes LLC ("M&F LLC"), which is the parent of MacAndrews & Forbes Group LLC ("M&F Group"). The ROP Revocable Trust is also the sole stockholder of Thirty Six East Corporation ("Thirty Six East"). M&F Group, MFV and Thirty Six East hold the securities described above. (cont'd on FN 2)
F2: (cont'd from FN 1) Mr. Perelman, the ROP Revocable Trust, M&F Inc., M&F LLC, M&F Group, MFV and Thirty Six East may be deemed to be directors by deputization of vTv Therapeutics Inc. (the "Issuer") by virtue of the role of Rich Nelson, director of the Issuer, as Executive Vice President Corporate and Business Development of Vericast and certain rights of M&F TTP Holdings Two LLC, an indirect subsidiary of M&F Inc. ("M&F TTP"), pursuant to the Investor Rights Agreement, dated as of July 29, 2015, between the Issuer and M&F TTP, as successor in interest to vTv Therapeutics Holdings LLC.